J. Bigorra / F. Bosch
Dr.Antonio Esteve Foundation
TORRE ESTEVEPasseig de la Zona Franca, 109
93 433 53 20
J. Bigorra / F. Bosch
Year of publication
In the context of crisis such as today’s, when public investments in scientific research have gone back to figures of the past, it has become essential to seek new sources of funding. These sources include philanthropy. Donations and sponsorship in all their different forms are becoming increasingly more important in funding biomedical research and innovation.
Six experts in attracting private resources for science present the book Filantropía en investigación e innovación biosanitarias en Cataluña (Philanthropy in biosanitary research and innovation in Catalonia), a new Notebook of the Esteve Foundation, and coordinated by Joan Bigorra (Hospital Clínic) and Fèlix Bosch (Esteve Foundation), which analyzes today’s situation in Catalonia and Spain, and the methods which are producing the best results.
According to data from Ricard Valls, of the Zohar consultance, the philanthropy market in Spain represented a total of 1,179 million euros in 2011, of which 13% (160 million) were assigned to research. This figure is equivalent to 0.8% of expenditure in R&D in Spain, and which, according to Valls, could increase with the reform of the Spanish patronage law.
Ignasi Costas, of the law firm Rousaud Costas Duran looks at the details of the State Law 49/2002 which governs patronage in Spain. He also analyzes legislative changes, which have been on the political agenda for some time, and which include improvements in tax incentives for donations.
Lluís Pareras, of the Department of Innovation and Technology of the Official College of Doctors of Barcelona, and director of ‘Healthequity’, analyzes new methods of philanthropy, such as micro-patronage and ‘venture philanthropy’, which join philanthropy as a donation and philanthropy as an investment. Up until now, these methods had been separate.
One of the fundamental pillars of scientific philanthropy in Spain is “Obra Social La Caixa” (La Caixa Social Work), which between 2007 and 2013 has allocated 88 million euros to research. Enric Banda, director of Science, Research and Environment, explains in the book how the involvement of entities in the projects they fund has increased.
Lastly, Josep María Piqué, director of the Fundación Hospital Clínic of Barcelona, and Jordi Camí, director of the Fundación Pasqual Maragall, describe the strategy of institutions to obtain private resources in a professional manner.
|Complete document||J. Bigorra / F. Bosch||[wpdm id=1273 type=”btn”]|
|Presentation||J. Bigorra / F. Bosch||[wpdm id=1274 type=”btn”]|
|Participants||[wpdm id=1275 type=”btn”]|
|1. Business philanthropy and micro-patronage in biomedical research||Ll. Pareras||[wpdm id=1276 type=”btn”]|
|2. The market of attracting private resources. Barriers and possibilities in the field of research||R. Valls||[wpdm id=1277 type=”btn”]|
|3. The patronage law: current situation and upcoming modifications||I. Costas||[wpdm id=1278 type=”btn”]|
|4. Perspective from a scientific foundation: the Fundación Pasqual Maragall||J. Camí||[wpdm id=1279 type=”btn”]|
|5. Perspective from a hospital foundation: the Fundación Hospital Clínic||JM. Piqué||[wpdm id=1280 type=”btn”]|
|6. Philanthropy and biomedical research in Catalonia in a global context||E. Banda||[wpdm id=1281 type=”btn”]|
|A donation for science, please. Summary of the seminar Philanthropy in biosanitary research and innovation in Catalonia||P. Morales||[wpdm id=1282 type=”btn”]|
|Review of the role of philanthropy in biomedical research and innovation||J. Bigorra / F. Bosch / J. Esteve||[wpdm id=1283 type=”btn”]|
|Proposals and recommendations||[wpdm id=1284 type=”btn”]|